Functional amyloid formation within mammalian tissue.
Amyloid is a generally insoluble, fibrous cross-beta sheet protein aggregate. The process of amyloidogenesis is associated with a variety of neurodegenerative diseases including Alzheimer, Parkinson, and Huntington disease. We report the discovery of an unprecedented functional mammalian amyloid str...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2006-01-01
|
Series: | PLoS Biology |
Online Access: | https://doi.org/10.1371/journal.pbio.0040006 |
id |
doaj-753dcaaa8cb74e819c61f52270d806e1 |
---|---|
record_format |
Article |
spelling |
doaj-753dcaaa8cb74e819c61f52270d806e12021-07-02T16:29:12ZengPublic Library of Science (PLoS)PLoS Biology1544-91731545-78852006-01-0141e610.1371/journal.pbio.0040006Functional amyloid formation within mammalian tissue.Douglas M FowlerAtanas V KoulovChristelle Alory-JostMichael S MarksWilliam E BalchJeffery W KellyAmyloid is a generally insoluble, fibrous cross-beta sheet protein aggregate. The process of amyloidogenesis is associated with a variety of neurodegenerative diseases including Alzheimer, Parkinson, and Huntington disease. We report the discovery of an unprecedented functional mammalian amyloid structure generated by the protein Pmel17. This discovery demonstrates that amyloid is a fundamental nonpathological protein fold utilized by organisms from bacteria to humans. We have found that Pmel17 amyloid templates and accelerates the covalent polymerization of reactive small molecules into melanin-a critically important biopolymer that protects against a broad range of cytotoxic insults including UV and oxidative damage. Pmel17 amyloid also appears to play a role in mitigating the toxicity associated with melanin formation by sequestering and minimizing diffusion of highly reactive, toxic melanin precursors out of the melanosome. Intracellular Pmel17 amyloidogenesis is carefully orchestrated by the secretory pathway, utilizing membrane sequestration and proteolytic steps to protect the cell from amyloid and amyloidogenic intermediates that can be toxic. While functional and pathological amyloid share similar structural features, critical differences in packaging and kinetics of assembly enable the usage of Pmel17 amyloid for normal function. The discovery of native Pmel17 amyloid in mammals provides key insight into the molecular basis of both melanin formation and amyloid pathology, and demonstrates that native amyloid (amyloidin) may be an ancient, evolutionarily conserved protein quaternary structure underpinning diverse pathways contributing to normal cell and tissue physiology.https://doi.org/10.1371/journal.pbio.0040006 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Douglas M Fowler Atanas V Koulov Christelle Alory-Jost Michael S Marks William E Balch Jeffery W Kelly |
spellingShingle |
Douglas M Fowler Atanas V Koulov Christelle Alory-Jost Michael S Marks William E Balch Jeffery W Kelly Functional amyloid formation within mammalian tissue. PLoS Biology |
author_facet |
Douglas M Fowler Atanas V Koulov Christelle Alory-Jost Michael S Marks William E Balch Jeffery W Kelly |
author_sort |
Douglas M Fowler |
title |
Functional amyloid formation within mammalian tissue. |
title_short |
Functional amyloid formation within mammalian tissue. |
title_full |
Functional amyloid formation within mammalian tissue. |
title_fullStr |
Functional amyloid formation within mammalian tissue. |
title_full_unstemmed |
Functional amyloid formation within mammalian tissue. |
title_sort |
functional amyloid formation within mammalian tissue. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Biology |
issn |
1544-9173 1545-7885 |
publishDate |
2006-01-01 |
description |
Amyloid is a generally insoluble, fibrous cross-beta sheet protein aggregate. The process of amyloidogenesis is associated with a variety of neurodegenerative diseases including Alzheimer, Parkinson, and Huntington disease. We report the discovery of an unprecedented functional mammalian amyloid structure generated by the protein Pmel17. This discovery demonstrates that amyloid is a fundamental nonpathological protein fold utilized by organisms from bacteria to humans. We have found that Pmel17 amyloid templates and accelerates the covalent polymerization of reactive small molecules into melanin-a critically important biopolymer that protects against a broad range of cytotoxic insults including UV and oxidative damage. Pmel17 amyloid also appears to play a role in mitigating the toxicity associated with melanin formation by sequestering and minimizing diffusion of highly reactive, toxic melanin precursors out of the melanosome. Intracellular Pmel17 amyloidogenesis is carefully orchestrated by the secretory pathway, utilizing membrane sequestration and proteolytic steps to protect the cell from amyloid and amyloidogenic intermediates that can be toxic. While functional and pathological amyloid share similar structural features, critical differences in packaging and kinetics of assembly enable the usage of Pmel17 amyloid for normal function. The discovery of native Pmel17 amyloid in mammals provides key insight into the molecular basis of both melanin formation and amyloid pathology, and demonstrates that native amyloid (amyloidin) may be an ancient, evolutionarily conserved protein quaternary structure underpinning diverse pathways contributing to normal cell and tissue physiology. |
url |
https://doi.org/10.1371/journal.pbio.0040006 |
work_keys_str_mv |
AT douglasmfowler functionalamyloidformationwithinmammaliantissue AT atanasvkoulov functionalamyloidformationwithinmammaliantissue AT christellealoryjost functionalamyloidformationwithinmammaliantissue AT michaelsmarks functionalamyloidformationwithinmammaliantissue AT williamebalch functionalamyloidformationwithinmammaliantissue AT jefferywkelly functionalamyloidformationwithinmammaliantissue |
_version_ |
1721326475114708992 |